KARYOPHARM THERAPEUTICS INC earnings per share and revenue

25K earnings per share for the last quarter are -2.56 EUR whereas the estimation was -4.08 EUR which accounts for 37.32% surprise. Company revenue for the same period amounts to 27.74 M EUR despite the estimated figure of 32.46 M EUR. Estimated earnings per share for the next quarter are -3.54 EUR, and revenue is expected to reach 32.97 M EUR. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.